US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 474 actively recruiting studies with Ohio sites out of 474 registered in total. The busiest research areas in Ohio are Acute Myeloid Leukemia, Endometrial Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include Children's Hospital Medical Center, Cincinnati, Ohio State University, The Cleveland Clinic. By stage, Ohio trials break down as Phase 1 (73), Phase 2 (129), Phase 3 (135), Phase 4 (17).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
474
Recruiting Now
474
← Back to US Map
Top Conditions in Ohio
Acute Myeloid Leukemia (8)Endometrial Cancer (7)Advanced Solid Tumor (6)Heart Failure (6)Multiple Myeloma (5)Ovarian Cancer (5)Stroke (5)Breast Cancer (5)Solid Tumor (4)Prostate Cancer (4)Autism Spectrum Disorder (4)Chronic Lymphocytic Leukemia (4)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 474 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 474. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Acute Myeloid Leukemia, Endometrial Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT00009633 N/A
Recruiting
Follow-up Visit of High Risk Infants
Condition
Infant, Newborn
Enrollment
68,000 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
View Trial →
NCT04580368 N/A
Recruiting
Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials
Condition
Cystic Fibrosis
Enrollment
50 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT06055608 Phase 2
Recruiting
Advancing Transplantation Outcomes in Children
Condition
Kidney Transplant
Enrollment
200 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT06059638 N/A
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Condition
Hypertension
Enrollment
316 pts
Location
United States, Australia, Belgium
Sponsor
Orchestra BioMed, Inc
View Trial →
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT03671889 N/A
Recruiting
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's D...
Condition
Alzheimer Disease
Enrollment
50 pts
Location
United States
Sponsor
InSightec
View Trial →
NCT04228978 N/A
Recruiting
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent...
Condition
Peripheral Artery Disease
Enrollment
212 pts
Location
United States
Sponsor
Northwestern University
View Trial →
NCT01524276 N/A
Recruiting
Product Surveillance Registry
Condition
Cardiac Rhythm Disorders
Enrollment
100,000 pts
Location
United States, Argentina, Australia
Sponsor
Medtronic
View Trial →
NCT05390918 N/A
Recruiting
Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
Condition
Insomnia
Enrollment
235 pts
Location
United States
Sponsor
Jeff Bridge
View Trial →
NCT07509190 N/A
Recruiting
Bridging the Gap: Educating Patients on Social Determinants of Health to Improve...
Condition
Epilepsy
Enrollment
310 pts
Location
United States
Sponsor
Anny Reyes
View Trial →
NCT07288216 Phase 2
Recruiting
Transition to KPL-387 Monotherapy Dosing & Administration Study
Condition
Recurrent Pericarditis
Enrollment
80 pts
Location
United States, Canada, France
Sponsor
Kiniksa Pharmaceuticals Intern
View Trial →
NCT07218926 Phase 3
Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastr...
Condition
Gastrointestinal Neoplasms
Enrollment
450 pts
Location
United States, Australia, Belgium
Sponsor
GlaxoSmithKline
View Trial →
NCT06311708 N/A
Recruiting
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Ad...
Condition
Arrhythmogenic Right Ventricular Cardiomyopathy
Enrollment
200 pts
Location
United States, France, Germany
Sponsor
Tenaya Therapeutics
View Trial →
NCT06857240 Phase 2
Recruiting
Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
Condition
Dermatomyositis
Enrollment
15 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT05778188 Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary ...
Condition
Hypoxic-Ischemic Encephalopathy
Enrollment
70 pts
Location
United States
Sponsor
ReAlta Life Sciences, Inc.
View Trial →
NCT06619561 Phase 2
Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host ...
Condition
Chronic Graft-Versus-Host Disease (cGVHD)
Enrollment
48 pts
Location
United States
Sponsor
Deciphera Pharmaceuticals, LLC
View Trial →
NCT05920356 Phase 3
Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab P...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT05654272 N/A
Recruiting
Development of CIRC Technologies
Condition
Cardiovascular Diseases
Enrollment
1,000 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT06152575 Phase 3
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in P...
Condition
Multiple Myeloma
Enrollment
492 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
View Trial →
NCT06978088 Phase 2
Recruiting
LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymph...
Condition
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Enrollment
34 pts
Location
United States
Sponsor
Zulfa Omer
View Trial →
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
LEO Pharma
View Trial →
NCT06672705 Phase 1
Recruiting
Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphopr...
Condition
Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
Enrollment
26 pts
Location
United States
Sponsor
Timothy Voorhees
View Trial →
NCT03802695 Phase 1
Recruiting
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation fo...
Condition
Acute Myeloid Leukemia
Enrollment
300 pts
Location
United States
Sponsor
Orca Biosystems, Inc.
View Trial →
NCT06673095 N/A
Recruiting
Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive C...
Condition
Clinical Stage IA Cutaneous Melanoma AJCC v8
Enrollment
1,000 pts
Location
United States
Sponsor
OHSU Knight Cancer Institute
View Trial →
NCT04775745 Phase 1
Recruiting
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B...
Condition
CLL/SLL
Enrollment
60 pts
Location
United States
Sponsor
Newave Pharmaceutical Inc
View Trial →
Page 3 of 19 — 474 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology